Skip to main content
Equibles
SPRB logo

SPRB · Spruce Biosciences, Inc. · Metrics

Track SPRB — free

Use SPRB with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SPRB.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$55.50 -0.25 (-0.44%)
Russell 2000 member Rebalance outlook locked
Market Cap
$160.20M
Shares
2.87M

SPRB metrics

55 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$55.74
Market cap
$160.20M

Price action

20 metrics
Price change (1W)
+6.3%
Price change (30D)
+27.9%
Price change (3M)
+20.5%
Price change (6M)
-5.9%
Price change (YTD)
-32.2%
Price change (1Y)
+556.6%
Trailing year
Price change (5Y)
—
52-week high
$182.60
52-week low
$7.75
Change from 52-week high
-67.6%
Change from 52-week low
+662.5%
Annualized volatility
1,385.8%
Annualized volatility (3M)
61.4%
Beta
3.7
RSI (14D)
59.3
Price vs SMA 50
+17.2%
Price vs SMA 200
-6.7%
Avg volume (3M)
75,842
Relative volume
2.6
Average dollar volume
$3.97M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
2.87M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
2.0
reciprocal yield 50.3%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-30.8%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
15.0×
reciprocal yield 6.6%
EV / revenue historical average (5Y)
15.0×
reciprocal yield 6.6%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2024-11-12

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$47.83M
Net income (TTM)
−$51.35M
Trailing 12 months
Diluted EPS (TTM)
$-39.00
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$30.99

Growth

11 metrics
Revenue growth YoY
-100.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$0
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+311.3%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-61.3%
Return on assets
-49.9%
Debt / equity
0.1
Current ratio
9.2
EBITDA (TTM)
−$46.94M
Free cash flow (TTM)
—
Quick ratio
9.2
Interest coverage
-26.6
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$96.30M
Total assets
$102.85M
Total debt
$7.09M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$42.62M
Capital expenditures (TTM)
—
R&D (TTM)
$28.85M
SG&A (TTM)
—
Stock compensation (TTM)
$3.67M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
63
13F filer change QoQ
+31
Institutional ownership
69.7%

Short interest

3 metrics
Short interest
14.0%
Latest settlement · 10.4 days to cover
Days to cover
10.4d
Short-squeeze score
93 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1683553 CUSIP 85209E208 13F (30d) 46 filings 46 filers Visit website Investor relations